Treatment-experienced patients with HIV and viremia achieve high virologic suppression with long-acting CAB/RPV.

Patient COVID-19 status does not significantly alter the microbiology of device-associated hospital-acquired infections or ...

Switching to a once-daily bictegravir/lenacapavir (BIC/LEN) single-tablet regimen is generally well tolerated through 48 ...

At IDWeek 2026, Paul Sax, MD, and Cynthia Sears, MD, highlighted practice-changing developments bridging clinical infectious ...

The Infectious Disease Advisor team will be covering emerging research and key takeaways from IDWeek 2026, as well as ...

During the 2024-2025 season, influenza vaccination effectively lowered the risk for hospitalization and severe inpatient outcomes among adults.

In people living with HIV and advanced solid tumors who are receiving antiretroviral therapy, treatment with nivolumab plus cabozantinib is safe.

Products that promise relief from genital herpes are easy to order online, but none of them are approved to treat the infection.

Quadrivalent HPV vaccination before pregnancy is associated with a lower risk for adverse pregnancy outcomes, including preterm birth.

The quadrivalent HPV vaccine provides durable immune responses and protects against cervical disease in women with HIV.

The administration of live vaccines to patients with inflammatory bowel disease receiving advanced therapies did not result in an increased risk for short-term hospitalizations, emergency department ...

Updated recommendations were presented for the management of UTIs in infants and children younger than 5 years in a recent guideline.